the decreased gaba level in csf , which was elevated by levodopa , supports the concept that in parkinson 's disease , the gaba-dopamine interaction in the substantia nigra may be an important compensatory mechanism counteracting the dopamine neuronal loss .
C0023570
levodopa
C0030567
parkinson 's disease